These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 354473)

  • 1. The macrophage electrophoretic mobility (MEM) test--an investigation of its value as a routine laboratory test in the detection of malignant disease.
    Pritchard JA; Sutherland WH; Teasdale C; Whitehead RH; Deeley TJ; Hughes LE
    Ann Clin Res; 1978 Apr; 10(2):71-4. PubMed ID: 354473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
    Preece AW; Light PA
    Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease.
    Pritchard JA; Moore JL; Sutherland WH; Joslin CA
    Br J Cancer Suppl; 1973 Aug; 1():229-36. PubMed ID: 4804283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity in the MEM-test of cancer patients' lymphocytes incubated with brain-derived preparations and extracts from malignant teratomas.
    Müller M; Irmscher J; Grossmann H; Kotzsch M; Wagner H; Kemmer C
    Arch Geschwulstforsch; 1981; 51(4):354-63. PubMed ID: 6172087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies with the macrophage migration inhibition (MMI) test in patients with malignant disease.
    Light PA; Preece AW; Waldron HA
    Clin Exp Immunol; 1975 Nov; 22(2):279-84. PubMed ID: 55328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pre- and postoperative reactivity of breast cancer patients to tumor associated antigens and HEP in the macrophage electrophoresis mobility (MEM) test].
    Ladusch M; Schäffner H; Ullmann L; Littmann M; Reimann S; Gindl P; Ambrosius H
    Arch Geschwulstforsch; 1982; 52(6):469-78. PubMed ID: 6186223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reaction of inhibition of macrophage electrophoretic mobility in differential diagnosis of carcinomas].
    Miuller M; Irmsher Iu; Fisher R; Grosmann G
    Vopr Onkol; 1976; 22(12):43-50. PubMed ID: 1020256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivity of human lymphocytes to teratoma preparations as revealed by the macrophage electrophoretic mobility (MEM) technique.
    Irmscher J; Grossmann H; Kotzsch M; Wagner H; Müller M
    Arch Geschwulstforsch; 1982; 52(5):349-53. PubMed ID: 7149908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of the macrophage electrophoretic mobility test (MEM) in cancer diagnosis.
    Crozier EH; Hollinger ME; Woodend BE; Robertson JH
    J Clin Pathol; 1976 Jul; 29(7):608-9. PubMed ID: 988059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
    Field EJ; Caspary EA; Smith KS
    Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunodiagnosis of urologic tumors].
    Günther M; Friedrich A; Jenssen HL; Werner H; Köhler H; Seyfarth M; Erdmann T
    Z Urol Nephrol; 1977 May; 70(4):225-30. PubMed ID: 331743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine clinical application of the lymphocyte fluorescence polarization test for malignant disease.
    Bater AJ; Siddall JE; Pritchard JA; Kerby IJ
    Cancer Detect Prev; 1988; 11(3-6):163-71. PubMed ID: 3390841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Macrophage electrophoretic mobility test (MEM) and tanned erythrocyte electrophoretic mobility test (TEEM) for cancer diagnosis (author's transl)].
    Zhao BH; Hu JK; Liang JX
    Zhonghua Zhong Liu Za Zhi; 1979; 1(3):195-200. PubMed ID: 553795
    [No Abstract]   [Full Text] [Related]  

  • 14. The macrophage electrophoretic mobility test for malignancy.
    Lubran MM
    Ann Clin Lab Sci; 1974; 4(2):121-4. PubMed ID: 4132114
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical assessment of the MOD-MEM cancer test in controls with non-malignant diseases.
    Pritchard JA; Moore JL; Sutherland WH; Joslin CA
    Br J Cancer; 1976 Jul; 34(1):1-6. PubMed ID: 60118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunodiagnosis of malignant tumors. Test of electrophoretic mobility of macrophages].
    Strejcek J; Jíra M; Suhajová E; Písa P; Malbohan I
    Cas Lek Cesk; 1984 Apr; 123(17):511-6. PubMed ID: 6380732
    [No Abstract]   [Full Text] [Related]  

  • 17. [The macrophage electrophoresis mobility (MEM) test for detection of cell sensitivity: technical analyses. I. Guinea pig peritoneal cells as indicator cells in the MEM test].
    Gryschek G; Schlott B; Strecker K
    Acta Biol Med Ger; 1982; 41(9):837-46. PubMed ID: 7164703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization of normal mouse lymphocytes immunized in vitro as detected by macrophage electrophoretic mobility (MEM) test.
    Nĕmecková S; Bubeník J; Indrová M
    Folia Biol (Praha); 1982; 28(4):280-2. PubMed ID: 7141039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The macrophage electrophoretic mobility assay in patients with renal cell carcinoma.
    Malkovský M; Bubeník J; Jakoubková J; Suhajová E; Indrová M; Jandlová T; Símová J
    Neoplasma; 1981; 28(2):245-51. PubMed ID: 7254439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of the MSF (macrophage slowing factor) release by phytohemagglutinin using the macrophage electrophoretic mobility test (MEM test). I. Dependency of release on incubation time, phytohemagglutinin and cell concentration].
    Metzner G; Jäger L
    Acta Biol Med Ger; 1980; 39(2-3):223-7. PubMed ID: 6999821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.